|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depression | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Chronic Disease | |||||
| Depressive Disorder | |||||
| Depressive Disorder, Major | |||||
| Lung Diseases | |||||
| Pulmonary Disease, Chronic Obstructive | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| Disease Attributes | |||||
| Lung Diseases, Obstructive | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| Pathologic Processes | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Problem-solving therapy (PST) | |||||
| Adherence-enhanced procedures (AE) | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||